InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,694.92
(
-0.33%
)
US TECH 100
19,272.00
(
-0.32%
)
Dow Jones
42,035.89
(
0.03%
)
Brent Oil
74.20
(
-0.17%
)
Bitcoin
62,644.03
(
-0.49%
)
Post# of 20617
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Biotech Pharmer

Send PM Follow Ignore
Followers 0
Posts 1521
Boards Moderated 0
Alias Born 09/16/2005

Biotech Pharmer

Re: mulally post# 11352

Tuesday, 08/22/2017 3:42:35 PM

Tuesday, August 22, 2017 3:42:35 PM

Post# of 20617
I contend that INNV will be 20% less than current price at the end of the year(.08-.09). Damaj's continued over promising & under delivering on guidance and FDA timelines will again rear its ugly head, and the market has already lost its patience with it. Why buy now at .11-.12 when you can invest elsewhere and actually make some money and then make your entry in INNV at .09-.09 in Q1'18?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up